Literature DB >> 8307142

In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.

A S Sekhon1, A K Garg, A A Padhye, Z Hamir.   

Abstract

The mycelial (25 degrees C) and yeast-like (37 degrees C) forms of Penicillium marneffei clinical and type strains were investigated for their in vitro susceptibility to amphotericin B (AmB), 5-fluorocytosine (5-FC), fluconazole (FLU) and itraconazole (ITZ), using Bacto antibiotic medium 3, yeast-nitrogen, Sabouraud's dextrose (pH 5.7) and high resolution (pH 7.1) broth media (1ml/tube), respectively. Results indicated that the minimal inhibitory and minimal fungicidal concentrations (MICs and MFCs) for the mycelial cultures of P. marneffei to AmB were in the range 0.78-1.56 and 0.78-3.125 micrograms/ml, respectively, as against 3.125-25 micrograms (MICs) for the yeast form cultures. The MFCs to AmB for the yeast form were one dilution higher. The MICs to FLU were generally lower for the yeast form (6.25-25 micrograms) than the mycelial form (25-50 micrograms/ml), whereas MFCs for the mycelial cultures were > 100 micrograms as compared to 6.25-100 micrograms for their yeast form. The MICs for the mycelial form to 5-FC ranged from < 0.195-0.39 microgram. Higher MICs (6.25 micrograms) were recorded for their yeast form. The MFCs to 5-FC for the yeast form were 25-100 micrograms/ml. The MICs for the mycelial form to ITZ ranged from < 0.195 to 3.125 micrograms/ml. Higher values (< 0.195-50 micrograms) were recorded for their yeast-like form. The MFCs to ITZ for mycelial and yeast forms ranged from < 0.195-0.39 and 25-100 micrograms/ml, respectively. Results indicate that P. marneffei's yeast form is more sensitive to FLU and ITZ (8 of 10 strains) while the mycelial form displayed greater susceptibility to AmB and 5-FC. The MICs for ITZ remained steady in SD medium, pH 5.7 to 7.1. However, some strains gave higher MIC values (0.39-1.56 micrograms/ml) when tested in the HR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307142     DOI: 10.1007/BF00209535

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  8 in total

1.  Standardized susceptibility testing of fluconazole: an international collaborative study.

Authors:  M A Pfaller; B Dupont; G S Kobayashi; J Müller; M G Rinaldi; A Espinel-Ingroff; S Shadomy; P F Troke; T J Walsh; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  [Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system].

Authors:  G SEGRETAIN
Journal:  Mycopathol Mycol Appl       Date:  1959-11-30

3.  [Penicillosis from Rhizomys sinensis].

Authors:  M CAPPONI; G SEGRETAIN; P SUREAU
Journal:  Bull Soc Pathol Exot Filiales       Date:  1956 May-Jun

4.  Infection caused by Penicillium marneffei: description of first natural infection in man.

Authors:  A F DiSalvo; A M Fickling; L Ajello
Journal:  Am J Clin Pathol       Date:  1973-08       Impact factor: 2.493

5.  In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.

Authors:  A S Sekhon; A Funk
Journal:  J Antimicrob Chemother       Date:  1977-01       Impact factor: 5.790

6.  Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.

Authors:  A S Sekhon; A K Garg; Z Hamir
Journal:  Mycoses       Date:  1991 Jul-Aug       Impact factor: 4.377

7.  Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme.

Authors:  G P Melcher; D A McGough; A W Fothergill; C Norris; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  8 in total
  10 in total

1.  In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Authors:  Borann Sar; Sambo Boy; Chantary Keo; Chan Chhaya Ngeth; Narom Prak; Mich Vann; Didier Monchy; Jean Louis Sarthou
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Penicillium marneffei: types and drug susceptibility.

Authors:  P Imwidthaya; K Thipsuvan; A Chaiprasert; S Danchaivijitra; R Sutthent; J Jearanaisilavong
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 3.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

4.  In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.

Authors:  Susanna K P Lau; George C S Lo; Clare S K Lam; Wang-Ngai Chow; Antonio H Y Ngan; Alan K L Wu; Dominic N C Tsang; Cindy W S Tse; Tak-Lun Que; Bone S F Tang; Patrick C Y Woo
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

5.  Subcutaneous mycoses: an aetiological study of 15 cases in a tertiary care hospital at Dibrugarh, Assam, northeast India.

Authors:  Pallabi Bordoloi; Reema Nath; Mondita Borgohain; M M Huda; Shyamanta Barua; Debajit Dutta; Lahari Saikia
Journal:  Mycopathologia       Date:  2015-01-18       Impact factor: 2.574

6.  Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

7.  Pulmonary penicillosis marneffei: report of the first imported case in Canada.

Authors:  A S Sekhon; L Stein; A K Garg; W A Black; J D Glezos; C Wong
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

8.  Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages.

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

9.  In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.

Authors:  Toru Nakai; Jun Uno; Fumiaki Ikeda; Shuichi Tawara; Kazuko Nishimura; Makoto Miyaji
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Penicillium marneffei Infection in AIDS.

Authors:  Stephenie Y N Wong; K F Wong
Journal:  Patholog Res Int       Date:  2011-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.